PET/CT helps predict mortality in metastatic breast cancer patients

09/14/2011 | AuntMinnie.com (free registration)

Researchers at last week's American Society of Clinical Oncology Breast Cancer Symposium reported that in breast cancer patients with bone metastases, higher standardized uptake values on PET/CT scans could indicate greater risk of death. Prognostication for metastatic breast cancer has been difficult, but modern PET/CT may serve as a "complementary and clinically useful prognostic tool," said researcher Dr. Komal Jhaveri from the Memorial Sloan-Kettering Cancer Center in New York.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX